Chester County News and Community Website
FORT WASHINGTON, PA — Luxury home builder, Toll Brothers, Inc. (NYSE: TOL), this week announced its financial results for the fourth quarter and full fiscal year ended October 31, 2023.
Toll Brothers Reports Fourth Quarter and Full Year Results for FY 2023 Read MorePHILADELPHIA, PA — Five Below, Inc. (NASDAQ: FIVE), the trend-right, value-driven retailer, recently announced its third-quarter fiscal results for 2023 and offered an optimistic outlook for the remainder of the …
Five Below Reports Solid Growth in Q3 2023, Forecasts Promising Outlook for Fiscal Year End Read More
PHILADELPHIA, PA — Urban Outfitters, Inc. (NASDAQ: URBN) recently announced a net income of $83.0 million and earnings per diluted share of $0.88 for the three months ended October 31, …
Urban Outfitters Reports Record Net Sales and Improved Gross Profit Rate for Q3 2023 Read More
VALLEY FORGE, PA — UGI Corporation (NYSE: UGI), a leading distributor of energy products and services, recently released its financial results for the fiscal year ended September 30, 2023, and …
UGI Corporation Reports Fiscal 2023 Financial Results, Provides 2024 Outlook Read More
BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) has recently revealed its financial results for the third quarter ending September 30, 2023, alongside a series of significant developments.
Virpax Pharmaceuticals Reports Third Quarter 2023 Financial Results and Announces New Developments Read More
RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) recently released its Q3 2023 financial results, revealing several improvements compared to the same period last year. The company also provided an …
NRx Pharmaceuticals Reports Improved Financial Results for Q3 2023, Decrease in Net Loss Read More
BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) this week reported its third quarter operating and financial results.
Larimar Therapeutics Reports Third Quarter 2023 Operating and Financial Results Read More
MALVERN, PA — Galera Therapeutics, Inc. (NASDAQ: GRTX) this week unveiled its financial results for the third quarter of 2023, alongside a series of significant corporate updates that signal a …
Galera Therapeutics Reports Q3 2023 Financial Results Amid Strategic Shift Read More
CHESTERBROOK, PA — Biopharmaceutical company Trevena, Inc. (NASDAQ: TRVN) has reported its Q3 2023 financial results, shedding light on a net loss attributable to common stockholders of $7.9 million, or …
Trevena Reports Promising Q3 2023 Results, Reveals Progress in TRV045 Studies and OLINVYK Sales Read More
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) this week reported its third quarter 2023 financial results and provided a business update.
Orchestra BioMed Reports Third Quarter 2023 Financial Results, Provides Business Update Read More